How to Give Atropine in Bradycardia
For adults with symptomatic bradycardia, administer atropine 0.5 mg intravenously, repeated every 5 minutes as needed up to a maximum total dose of 2 mg. 1, 2
Adult Dosing Algorithm
Initial Dose
- Standard dose: 0.5 mg IV push 1, 2
- Alternative: 1.0 mg IV may be more effective for first-dose success 3
- Peak effect occurs within 3 minutes 1
Repeat Dosing
- If inadequate response, repeat 0.5 mg IV every 5 minutes 1
- Maximum total dose: 2.0 mg (achieves complete vagal blockade) 1, 2
- For asystole specifically: 1 mg IV, repeated every 5 minutes up to 2.5 mg total over 2.5 hours 1
Special Populations
Coronary Artery Disease:
- Limit total dose to 0.03-0.04 mg/kg to minimize risk of increased myocardial oxygen demand and ischemia 4
- Use caution as atropine-induced tachycardia may worsen ischemia or precipitate ventricular arrhythmias 2
Post-Heart Transplant:
- Atropine is contraindicated - may cause paradoxical heart block or sinus arrest in 20% of cases 5
- Use aminophylline (6 mg/kg IV over 20-30 min) or theophylline instead 5
Pediatric Dosing
Standard dose: 0.02 mg/kg IV/IO 6
Critical Dosing Parameters
- Minimum single dose: 0.1 mg (doses <0.1 mg historically thought to cause paradoxical bradycardia, though recent evidence questions this 7) 6
- Maximum single dose:
- Maximum total dose:
- Repeat every 5 minutes as needed 6
Alternative Routes (Pediatric)
- Endotracheal (ET):
- Intramuscular (IM): 0.02-0.04 mg/kg 6
When to Use Atropine (Class I Indications)
Symptomatic bradycardia with:
- Heart rate <50 bpm with hypotension 2
- Signs of peripheral hypoperfusion (confusion, pallor, hypotension) 1
- Frequent premature ventricular contractions 1
- Escape ventricular arrhythmias 2
Specific scenarios:
- Type I second-degree AV block (especially with inferior MI) 1, 2
- Third-degree AV block at AV nodal level (narrow-complex escape rhythm) 2
- Bradycardia after nitroglycerin administration 1
- Ventricular asystole 1, 2
When NOT to Use Atropine (Class III - Contraindicated)
- Asymptomatic bradycardia 2
- Type II second-degree AV block (may worsen block) 1
- Third-degree AV block with wide-complex escape (infranodal block, usually anterior MI) 2
- Post-heart transplant patients 5
Critical Pitfalls to Avoid
The Paradoxical Bradycardia Myth
Doses <0.5 mg may cause paradoxical slowing through central vagal stimulation 1, 2, 1. However, recent pediatric evidence challenges this dogma 7. In adults, always use at least 0.5 mg to avoid this risk 2.
Route Matters
Only intravenous administration is reliable for acute bradycardia 1. Non-IV routes may result in paradoxical effects 1. Endotracheal administration is acceptable when IV access is impossible 8, but requires higher doses 6.
Monitoring Requirements
- Watch for excessive tachycardia - may increase myocardial oxygen demand and worsen ischemia 1, 2
- Rarely, atropine can precipitate ventricular tachycardia or fibrillation 1
- CNS effects with repeated dosing: hallucinations, fever 1
When Atropine Fails
Prepare for transcutaneous or transvenous pacing if:
- No response after maximum atropine dose 1
- Infranodal block (Type II or third-degree with wide QRS) 2
- Hemodynamic instability persists 2
Consider alternative agents:
- Dopamine: 5-20 mcg/kg/min 5
- Epinephrine: 2-10 mcg/min 5
- Isoproterenol: 2-10 mcg/min (avoid in ischemia) 5
Evidence Quality Note
The dosing recommendations are based primarily on ACC/AHA guidelines from 1990-1996 1, 2, 1 and 2019 ACC/AHA/HRS guidelines 5, with pediatric guidance from 2008 AAP recommendations 6. Recent research suggests 1.0 mg may be superior to 0.5 mg for first-dose success in adults 3, though this represents a single retrospective study. The 2025 ILCOR pediatric guidelines withdrew previous atropine recommendations due to insufficient evidence 9, highlighting ongoing uncertainty in pediatric populations.